Terms: = Gastric cancer AND CCND2, KIAK0002, 894, ENSG00000118971, P30279, MGC102758 AND Treatment
18 results:
1. A CT-Based Radiomics Model for Evaluating Peritoneal cancer Index in Peritoneal Metastasis Cases: A Preliminary Study.
Zhang Q; Yuan Y; Li S; Li Z; Jing G; Lu J; Shao C; Hao Q; Lu Y; Shen F
Acad Radiol; 2023 Jul; 30(7):1329-1339. PubMed ID: 36180327
[TBL] [Abstract] [Full Text] [Related]
2. Long non-coding RNA TTTY15 silencing inhibits gastric cancer progression by sponging microRNA-98-5p to down-regulate cyclin D2 expression.
Wen X; Han W; Liu C
Bioengineered; 2022 Mar; 13(3):7380-7391. PubMed ID: 35266852
[TBL] [Abstract] [Full Text] [Related]
3. Determining oncogenic patterns and cancer predisposition through the transcriptomic profile in Mitchell-Riley syndrome with heterotopic gastric mucosa and duodenal atresia: a case report.
Calcaterra V; Chiricosta L; Mazzon E; Gugnandolo A; Alberti D; Maestri L; Meroni M; Vestri E; Verduci E; Dilillo D; Zuccotti G; Pelizzo G
Orphanet J Rare Dis; 2021 Oct; 16(1):455. PubMed ID: 34715892
[TBL] [Abstract] [Full Text] [Related]
4. Rebamipide for the Improvement of gastric Atrophy and Intestinal Metaplasia: A Prospective, Randomized, Pilot Study.
Lee JS; Jeon SW; Lee HS; Kwon YH; Nam SY; Bae HI; Seo AN
Dig Dis Sci; 2022 Jun; 67(6):2395-2402. PubMed ID: 34052947
[TBL] [Abstract] [Full Text] [Related]
5. Normal radiological lymph node appearance in the thorax.
Hansen T; Nilsson M; Lindholm D; Sundström J; Hedberg J
Dis Esophagus; 2019 Dec; 32(10):1-6. PubMed ID: 30561570
[TBL] [Abstract] [Full Text] [Related]
6. [Clinical study on lymph node metastasis regularity in 1456 patients with gastric cancer].
Liang J; Liang H; Deng J; Wang X; Wang X; Wu L
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1154-1160. PubMed ID: 30370515
[TBL] [Abstract] [Full Text] [Related]
7. treatment patterns and outcomes in patients with metastatic gastric cancer receiving third-line chemotherapy: A population-based outcomes study.
Choi IS; Choi M; Lee JH; Kim JH; Suh KJ; Lee JY; Kang B; Kim JW; Kim SH; Kim JW; Lee JO; Kim YJ; Bang SM; Lee JS; Lee KW
PLoS One; 2018; 13(6):e0198544. PubMed ID: 29879177
[TBL] [Abstract] [Full Text] [Related]
8. Nomogram analysis and external validation to predict the risk of lymph node metastasis in gastric cancer.
Chen S; Nie RC; OuYang LY; Li YF; Xiang J; Zhou ZW; Chen Y; Peng JS
Oncotarget; 2017 Feb; 8(7):11380-11388. PubMed ID: 28077786
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic significance of combined microRNA-206 and CyclinD2 in gastric cancer patients after curative surgery: A retrospective cohort study.
Shi H; Han J; Yue S; Zhang T; Zhu W; Zhang D
Biomed Pharmacother; 2015 Apr; 71():210-5. PubMed ID: 25960238
[TBL] [Abstract] [Full Text] [Related]
10. MicroRNA-29s could target AKT2 to inhibit gastric cancer cells invasion ability.
Zhang H; Cheng Y; Jia C; Yu S; Xiao Y; Chen J
Med Oncol; 2015 Jan; 32(1):342. PubMed ID: 25428377
[TBL] [Abstract] [Full Text] [Related]
11. Double-blind, placebo-controlled, randomized phase II study of TJ-14 (hangeshashinto) for gastric cancer chemotherapy-induced oral mucositis.
Aoyama T; Nishikawa K; Takiguchi N; Tanabe K; Imano M; Fukushima R; Sakamoto J; Oba MS; Morita S; Kono T; Tsuburaya A
Cancer Chemother Pharmacol; 2014 May; 73(5):1047-54. PubMed ID: 24652604
[TBL] [Abstract] [Full Text] [Related]
12. Characterization of microRNA-29 family expression and investigation of their mechanistic roles in gastric cancer.
Gong J; Li J; Wang Y; Liu C; Jia H; Jiang C; Wang Y; Luo M; Zhao H; Dong L; Song W; Wang F; Wang W; Zhang J; Yu J
Carcinogenesis; 2014 Feb; 35(2):497-506. PubMed ID: 24130168
[TBL] [Abstract] [Full Text] [Related]
13. Influence of a regional centralised upper gastrointestinal cancer service model on patient safety, quality of care and survival.
Chan DS; Reid TD; White C; Willicombe A; Blackshaw G; Clark GW; Havard TJ; Escofet X; Crosby TD; Roberts SA; Lewis WG
Clin Oncol (R Coll Radiol); 2013 Dec; 25(12):719-25. PubMed ID: 23994038
[TBL] [Abstract] [Full Text] [Related]
14. Efficacy of spraying l-menthol solution during endoscopic treatment of early gastric cancer: a phase III, multicenter, randomized, double-blind, placebo-controlled study.
Fujishiro M; Kaminishi M; Hiki N; Oda I; Fujisaki J; Uedo N; Kaise M; Tanabe S; Iguchi M; Matsuhashi N; Nomura S; Tajiri H; Yahagi N; Suzuki H
J Gastroenterol; 2014 Mar; 49(3):446-54. PubMed ID: 23800946
[TBL] [Abstract] [Full Text] [Related]
15. Early evaluation of cancer response by a new functional biomarker: apparent diffusion coefficient.
Sun YS; Cui Y; Tang L; Qi LP; Wang N; Zhang XY; Cao K; Zhang XP
AJR Am J Roentgenol; 2011 Jul; 197(1):W23-9. PubMed ID: 21700991
[TBL] [Abstract] [Full Text] [Related]
16. Cervical esophageal perforations at the time of endoscopic ultrasound: a prospective evaluation of frequency, outcomes, and patient management.
Eloubeidi MA; Tamhane A; Lopes TL; Morgan DE; Cerfolio RJ
Am J Gastroenterol; 2009 Jan; 104(1):53-6. PubMed ID: 19098849
[TBL] [Abstract] [Full Text] [Related]
17. Hedgehog signaling pathway and gastrointestinal stem cell signaling network (review).
Katoh Y; Katoh M
Int J Mol Med; 2006 Dec; 18(6):1019-23. PubMed ID: 17089004
[TBL] [Abstract] [Full Text] [Related]
18. Phase I and pharmacokinetic study of S-1 administered for 14 days in a 21-day cycle in patients with advanced upper gastrointestinal cancer.
Zhu AX; Clark JW; Ryan DP; Meyerhardt JA; Enzinger PC; Earle CC; Fuchs CS; Regan E; Anbe H; Houghton M; Zhang J; Urrea P; Kulke MH
Cancer Chemother Pharmacol; 2007 Feb; 59(3):285-93. PubMed ID: 16786333
[TBL] [Abstract] [Full Text] [Related]
